REPRONEX Trademark

Trademark Overview

On Wednesday, March 8, 2023, a trademark application was filed for REPRONEX with the United States Patent and Trademark Office. The USPTO has given the REPRONEX trademark a serial number of 97828166. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, June 17, 2024. This trademark is owned by Ferring B.V.. The REPRONEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of reproductive diseases and disorders
repronex

General Information

Serial Number97828166
Word MarkREPRONEX
Filing DateWednesday, March 8, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of reproductive diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL

Trademark Events

Event DateEvent Description
Saturday, March 11, 2023NEW APPLICATION ENTERED
Monday, March 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 19, 2023ASSIGNED TO EXAMINER
Thursday, April 20, 2023NON-FINAL ACTION WRITTEN
Thursday, April 20, 2023NON-FINAL ACTION E-MAILED
Thursday, April 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, June 1, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, October 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 17, 2024SOU EXTENSION 1 FILED
Monday, June 17, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024SOU EXTENSION 1 GRANTED
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Related Keywords

repronex diseases disorders reproductive treatment preparations pharmaceutical